Page last updated: 2024-11-01

ondansetron and Proteinuria

ondansetron has been researched along with Proteinuria in 1 studies

Ondansetron: A competitive serotonin type 3 receptor antagonist. It is effective in the treatment of nausea and vomiting caused by cytotoxic chemotherapy drugs, including cisplatin, and has reported anxiolytic and neuroleptic properties.

Proteinuria: The presence of proteins in the urine, an indicator of KIDNEY DISEASES.

Research Excerpts

ExcerptRelevanceReference
"Heptaplatin is a newly developed platinum derivative which has been reported to be less toxic than cisplatin."2.70Nephrotoxicity of heptaplatin: a randomized comparison with cisplatin in advanced gastric cancer. ( Ahn, JH; Bahng, H; Chang, HM; Kang, WC; Kang, YK; Kim, TW; Kim, WK; Lee, JS; Park, JS, 2002)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ahn, JH1
Kang, YK1
Kim, TW1
Bahng, H1
Chang, HM1
Kang, WC1
Kim, WK1
Lee, JS1
Park, JS1

Trials

1 trial available for ondansetron and Proteinuria

ArticleYear
Nephrotoxicity of heptaplatin: a randomized comparison with cisplatin in advanced gastric cancer.
    Cancer chemotherapy and pharmacology, 2002, Volume: 50, Issue:2

    Topics: Acute Disease; Adenocarcinoma; Adult; Aged; Antiemetics; Antineoplastic Combined Chemotherapy Protoc

2002